Conquering Complexity: The ongoing revolution in oncology biomarker testing

The clinical management of cancer patients has undergone a remarkable evolution in the last 15 years, with the concept of personalised medicine now well-entrenched in the treatment paradigm.

Conquering complexity | IpsosWe are also in the midst of much more radical revolution, however. The molecular diagnostics landscape – and the very way we think about fighting cancer – is set to change dramatically in the coming decades.

In this update of our 2017 edition of this paper, we combine new data from Ipsos’ Global Molecular Diagnostics Monitors with our current therapy expertise and market insight to outline key developments in the oncology diagnostics landscape, and the resulting impact on cancer treatment.

We also offer a forward-looking perspective on how we believe this landscape will shift, and how today’s touchpoints may look very different in years to come.

Download the full paper here.

Watch out for our upcoming podcast in which author, Pieter De Richter, talks us through the paper, offering his expert perspective on the future of oncology diagnostics. Details to follow.

More insights about Health

Related news

  • KEYS: Screen time

    [WEBINAR] KEYS: Screen time

    At our first KEYS webinar of the year we’ll be looking at what’s really happening on screens these days. What’s changing? What’s enduring? And how can businesses do better when it comes to engaging with people on their screens, in real time?
  • [Webinar] KEYS: What can we learn from what happened in 2025?
    Brand Image Webinar

    [Webinar] KEYS: What can we learn from what happened in 2025?

    In this final KEYS webinar of the year, we’ll be looking at the last 12 months through the rear-view mirror.
  • [Webinar] KEYS: THE MIDDLE CLASS: In Crisis?
    Society Webinar

    [Webinar] KEYS: THE MIDDLE CLASS: In Crisis?

    At our next KEYS webinar, we’ll be sharing on-the-ground perspectives as people give us their in-the-moment takes on how they see their lives - and their status in life - these days. Along the way we’ll hear about freedom (in the US), familismo (in Mexico) and understatedness (in the UK).